Halozyme Therapeutics News

Halozyme Therapeutics Analyst Ratings

BenzingaApr 17 11:39 ET

Halozyme Therapeutics Analyst Ratings

BenzingaApr 16 09:25 ET

TD Cowen Reaffirms Their Buy Rating on Halozyme (HALO)

TipRanksMar 8 07:26 ET

Halozyme Therapeutics Analyst Ratings

BenzingaFeb 21 06:44 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJan 19 11:51 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJan 18 06:17 ET

Morgan Stanley Maintains Overweight on Halozyme Therapeutics, Lowers Price Target to $59

BenzingaDec 26, 2023 10:46 ET

Halozyme Therapeutics Analyst Ratings

BenzingaDec 26, 2023 10:45 ET

Benchmark Reiterates Buy on Halozyme Therapeutics, Maintains $50 Price Target

BenzingaOct 20, 2023 10:28 ET

Halozyme Therapeutics Analyst Ratings

BenzingaOct 20, 2023 10:26 ET

Halozyme (HALO) Gets a Buy From Wells Fargo

TipRanksOct 20, 2023 04:47 ET

Halozyme Therapeutics Analyst Ratings

BenzingaOct 19, 2023 06:51 ET

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $60 Price Target

BenzingaOct 9, 2023 06:17 ET

Halozyme Therapeutics Analyst Ratings

BenzingaOct 9, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $60 Price Target

BenzingaSep 8, 2023 07:06 ET

Halozyme Therapeutics Analyst Ratings

BenzingaSep 8, 2023 07:06 ET

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $60 Price Target

BenzingaAug 30, 2023 06:08 ET

Halozyme Therapeutics Analyst Ratings

BenzingaAug 30, 2023 06:07 ET

HC Wainwright & Co. Maintains Buy on Halozyme Therapeutics, Lowers Price Target to $60

BenzingaAug 15, 2023 07:13 ET

Halozyme Therapeutics Analyst Ratings

BenzingaAug 15, 2023 07:11 ET